Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Novel Dengue Virus Inhibitor, BP13944, Discovered by High-Throughput Screening with Dengue Virus Replicon Cells Selects for Resistance in the Viral NS2B/NS3 Protease

22 Oct 2013

Abstract excerpt

Dengue virus (DENV) causes disease globally, resulting in an estimated 25 to 100 million new infections per year. No effective DENV vaccine is available, and the current treatment is only supportive. Thus, there is an urgent need to develop therapeutic agents to cure this epidemic disease. In the present study, we identified a potential small-molecule inhibitor, BP13944, via high-throughput screening (HTS) of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Malaria Research and Control
Share to Mosquito-borne diseases and control
Share to Viral Infections and Vectors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24145533
DOI: 10.1128/aac.01281-13

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Novel Dengue Virus Inhibitor, BP13944, Discovered by High-Throughput Screening with Dengue Virus Replicon Cells Selects for Resistance in the Viral NS2B/NS3 ProteasePMID 24145533Read ↗

Inhibition of Dengue Virus by Targeting Viral NS4B ProteinSemantic proximity Read ↗

Discovery of Dengue Virus NS4B InhibitorsSemantic proximity Read ↗

Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.Semantic proximity Read ↗

Discovery of a small molecule inhibitor targeting dengue virus NS5 RNA-dependent RNA polymeraseSemantic proximity Read ↗

Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.Semantic proximity Read ↗

Q63, a novel DENV2 RdRp non-nucleoside inhibitor, inhibited DENV2 replication and infectionSemantic proximity Read ↗

Mechanistic Insights into Dengue Virus Inhibition by a Clinical Trial Compound NITD-688Semantic proximity Read ↗

Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virusSemantic proximity Read ↗

Identification of Novel Small-Molecule Inhibitors of West Nile Virus InfectionSemantic proximity Read ↗

Identification of a small-molecule inhibitor of dengue virus using a replicon systemSemantic proximity Read ↗

Development and characterization of a stable luciferase dengue virus for high-throughput screening.Semantic proximity Read ↗

RK-33 Is a Broad-Spectrum Antiviral Agent That Targets DEAD-Box RNA Helicase DDX3XSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.